🇺🇸 FDA
Pipeline program

SAB-185

SAB-185-101

Phase 1 mab active

Quick answer

SAB-185 for COVID-19 is a Phase 1 program (mab) at SAB Biotherapeutics with 2 ClinicalTrials.gov record(s).

Program details

Company
SAB Biotherapeutics
Indication
COVID-19
Phase
Phase 1
Modality
mab
Status
active

Clinical trials